পৃষ্ঠা 1 থেকে 809 ফলাফল
RELATED APPLICATIONS
This application is incorporating by reference Japanese Patent Application No. 7-344947 filed on Dec. 5, 1995, which has the laid open publication (JP09-157236) date of Jun. 17, 1997.
FIELD OF THE INVENTION
The present invention relates to a phenylenediamine derivative and, in
STATEMENT REGARDING FEDERAL SPONSORED RESEARCH AND DEVELOPMENT
Not applicable.
BACKGROUND OF THE INVENTION
The subject of the present invention is, in the most general aspect, the prevention and/or treatment of a secondary edema. In particular, the present invention relates to a C1-Inhibitor for use
BACKGROUND OF THE INVENTION
(a) Field of the Invention
This invention relates to a novel therapeutic use of apovincaminic acid ethyl ester. More specifically this invention relates to a method for inhibiting pulmonary hemorrhage and edema associated with intracranial syndromes such as trauma, tumor,
FIELD OF THE INVENTION
The present invention relates to solute drainage catheters and, in particular, to a catheter for draining interstitial fluid from a cerebral edema.
BACKGROUND OF THE INVENTION
Cerebral edema is a type of brain swelling most commonly associated with cerebral trauma or mass
FIELD OF THE INVENTION
The present invention relates to solute drainage catheters and, in particular, to a catheter for draining interstitial fluid from a cerebral edema.
BACKGROUND OF THE INVENTION
Cerebral edema is a type of brain swelling most commonly associated with cerebral trauma or mass
TECHNICAL FIELD
This document pertains generally to medical systems, devices, or methods, and more particularly, but not by way of limitation, to systems and methods for monitoring pulmonary edema.
BACKGROUND
One hallmark of heart failure (HF) in a subject is congestion, more commonly referred to as
BACKGROUND
Surgery has always been a vital part of modern medicine to treat certain conditions that other interventional means cannot. However, surgical procedures are not without some significant complications, such as for example, hematomas, edema, and/or deep vein thrombosis.
Hematomas or blood
FIELD OF THE INVENTION
The invention provides novel polynucleotides and polypeptides associated with the incidence of PPAR-agonist induced edema. The invention also provides polynucleotide fragments corresponding to the genomic and/or coding regions of these polynucleotides which comprise at least
FIELD OF THE INVENTION
This invention relates to therapeutic compression systems and, in particular, to compression systems for the treatment of edema.
BACKGROUND OF THE INVENTION
The lymphatic system includes lymph vessels, lymph nodes, and lymphoid tissues. Lymphatic fluid, or lymph, is collected
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to a method for treatment of skin lesions and internal wounds such as viable but underperfused myocardium. More specifically, this invention is related to a method for treatment of a subject afflicted with
BACKGROUND
Certain conditions and diseases of the eye, such as corneal failure, keratoconus, corneal dystrophies, scarring, age related macular degeneration (AMD) and retinitis pigmentosa, have been treated using ocular transplant procedures such as corneal and retinal pigment epithelial (RPE)
GOVERNMENTAL SUPPORT
Research support for the present invention was provided by U.S. Public Health Service NHLB Grants Numbers HL16714 and HL33104.
FIELD OF THE INVENTION
The present invention is concerned with inflammatory and non-inflammatory associated edemas and is particularly directed to
FIELD OF THE INVENTION
The present invention is concerned with inflammatory and non-inflammatory (hydraulic) associated edemas and is particularly directed to prophylactic and therapeutic methods for treating localized and systemic edemas caused or mediated by interleukins.
BACKGROUND OF THE
CROSS REFERENCE TO RELATED APPLICATIONS
Applicant claims priority under 35 U.S.C. .sctn.119 of German Application No. 103 52 692.7 filed Nov. 12, 2003. Applicant also claims priority under 35 U.S.C. .sctn.365 of PCT/EP2004/012363 filed Nov. 2, 2004. The international application under PCT article
This application is a national phase of International Application No. PCT/EP2014/063193 filed Jun. 23, 2014 and published in the English language, which claims priority to Application No. EP 13173446.9 filed Jun. 24, 2013.
FIELD OF THE INVENTION
The present invention relates to pharmaceutically